NDC 51672-1387-08 - Dapsone
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-1387
- Requested NDC
- 51672-1387-08
- Package NDCs from labels
- 51672-1387-2, 51672-1387-3, 51672-1387-8, 51672-1387-08
- Manufacturer
- Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc.
- Effective date
- 2025-07-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Dapsone - Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | 2025-07-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-1387-2 | Dapsone | 30 g in 1 TUBE | GEL | 30 | 6 | |
| 51672-1387-2 | Dapsone | 1 in 1 CARTON | GEL | 1 | 6 | |
| 51672-1387-3 | Dapsone | 60 g in 1 TUBE | GEL | 60 | 6 | |
| 51672-1387-3 | Dapsone | 1 in 1 CARTON | GEL | 1 | 6 | |
| 51672-1387-8 | Dapsone | 1 in 1 CARTON | GEL | 1 | 6 | |
| 51672-1387-8 | Dapsone | 90 g in 1 TUBE | GEL | 90 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-1387 | DAPSONE GEL [TARO PHARMACEUTICALS U.S.A., INC.] | 5 | Current NDC, Legacy NDC, 6 package rows | 20250122_97e6444c-1496-4508-9434-8a2a93225e17.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-1387-3 | GM - Gram | 51672-1387 | 33e53a7e-2c7f-4d50-8165-1c7544452e58 | 1 | 2017-11-06 |
| 51672-1387-8 | GM - Gram | 51672-1387 | 15265e32-1da9-4b8d-9a07-871b94a9d4a3 | 1 | 2017-11-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dapsone | DAPSONE GEL, 5% | Trupharma, LLC | 699b6157-3245-43b6-91ee-c86ea262bc83 | 2025-09-05 | Warnings, Adverse reactions | 607295 8W5C518302 |
| Dapsone | DAPSONE | Trupharma, LLC | 2763bcbb-e249-be2b-e063-6394a90a5015 | 2025-09-05 | Warnings, Adverse reactions | 8W5C518302 |
| Dapsone | DAPSONE | Westminster Pharmaceuticals, LLC | 7d317576-5edd-4c27-a00d-68b5944c04a8 | 2025-08-28 | Warnings, Adverse reactions | 8W5C518302 |
| Sterile Water | WATER INJECTION | Henry Schein, Inc. | 3501952b-b556-4d5e-b81b-5c35ff87b475 | 2025-08-28 | Warnings, Adverse reactions | 059QF0KO0R |
| Dapsone | DAPSONE | Westminster Pharmaceuticals, LLC | d3fc4934-d48b-4a29-9022-0c82bbdad399 | 2025-08-15 | Warnings, Adverse reactions | 8W5C518302 |
| Sterile Water | STERILE WATER | Nephron Pharmaceuticals Corporation | bc04a883-babc-87a6-e053-2995a90a3dfd | 2025-07-11 | Warnings, Adverse reactions | 059QF0KO0R |
| Dapsone | DAPSONE | NORTHSTAR RX LLC | 91d027f1-cbc6-4066-870b-01b1ddb1f48f | 2025-07-09 | Warnings, Adverse reactions | ANDA209506 607295 8W5C518302 |
| Dapsone | DAPSONE | NORTHSTAR RX LLC | 51ebcb4d-4368-4748-a6f3-1ec2100fed63 | 2025-07-09 | Warnings, Adverse reactions | 8W5C518302 |
| Dapsone | DAPSONE | Sun Pharmaceutical Industries, Inc. | 32fcb7e0-5a6d-4d95-b81c-148012a54112 | 2025-07-02 | Warnings, Adverse reactions | 8W5C518302 |
| Dapsone | DAPSONE | Sun Pharmaceutical Industries, Inc. | 97e6444c-1496-4508-9434-8a2a93225e17 | 2025-07-01 | Warnings, Adverse reactions | ANDA209506 51672-1387-8 51672-1387-3 51672-1387-2 51672-1387 51672138708 607295 38e593e2-d4a5-b8dd-e063-6394a90a62c6 97e6444c-1496-4508-9434-8a2a93225e17 8W5C518302 |
| Plaque identifying | PLAQUE IDENTIFYING | Shenzhen Yagao Technology Co., Ltd. | 37eeb656-22f1-7372-e063-6394a90ad041 | 2025-06-19 | Warnings | 059QF0KO0R |
| Dapsone | DAPSONE | Mayne Pharma Commercial LLC | cbf9e81e-00ef-4218-975e-6a1610b7f1dd | 2025-06-09 | Warnings, Adverse reactions | 8W5C518302 |
| dapsone | DAPSONE | Torrent Pharmaceuticals Limited | f8cffc24-8310-4f21-ae77-7f6ad6095551 | 2025-06-05 | Warnings, Adverse reactions | 8W5C518302 |
| DAPSONE | DAPSONE | Aurobindo Pharma Limited | acd33f0b-8563-467a-93db-a11902331528 | 2025-05-30 | Warnings, Adverse reactions | 607295 8W5C518302 |
| Sterile Water | WATER | Henry Schein, Inc. | 88403fcf-a276-42c0-88b6-bd84a720b564 | 2025-05-29 | Warnings, Adverse reactions | 059QF0KO0R |
| Insecticides/Pest/Food Additives Detox | BOLDO, CARDUUS MARIANUS, CHELIDONIUM MAJUS, PETROSELINUM SATIVUM, TARAXACUM OFFICINALE, ARSENICUM ALBUM, BISPHENOL A, COBALTUM METALLICUM, CUPRUM METALLICUM, GLYPHOSATE, IODIUM, LYCOPODIUM CLAVATUM, PHOSPHORICUM ACIDUM, SELENIUM METALLICUM, ZINCUM METALLICUM, ASPARTAME, BENZALKONIUM CHLORIDE, FORMALINUM, METHYLENE CHLORIDE, METHYLPARABEN, PROPYLPARABEN, SODIUM BENZOATE, SODIUM CITRATE, TITANIUM DIOXIDE, ZINCUM OXYDATUM | Dr. Donna Restivo DC | b5778211-0e3e-44ef-bd65-a76a68cf1504 | 2025-05-23 | Warnings | A2I8C7HI9T |
| Eyesaline Emergency Eyewash | STERILE EYESALINE EYEWASH | Honeywell Safety Products USA, Inc. | 2d567518-4c54-7448-e063-6294a90a3e64 | 2025-05-14 | Warnings | 059QF0KO0R |
| Dapsone | DAPSONE | Chartwell RX, LLC | 93028aff-54f0-4f94-b925-a91400118294 | 2025-04-29 | Warnings, Adverse reactions | 8W5C518302 |
| Dapsone | DAPSONE | Alembic Pharmaceuticals Inc. | 2811f7de-13bf-45cd-8413-5b04d11f40ff | 2025-04-03 | Warnings, Adverse reactions | 8W5C518302 |
| Eye Wash | WATER | CMC Group Inc. | 6158a1f5-a6bc-4a3e-9d1d-0a310d9dc561 | 2025-04-02 | Warnings | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.